Abstract
The range of human phenotypes/diseases for which our burgeoning bio–molecular data base is sufficient to provide understanding, diagnosis, and therapy is small. Only 2 percent of our total disease load is related to monogenic causality, and even here the final phenotype is modulated by many factors. Monogenic logic cannot, moreover, be applied to the 98 percent of our most important sources of premature disability and death. This article provides an analysis of the limits of genetic thinking in biotechnology and describes the outline for another approach to understanding complex cellular/physiological systems. In this outline, rules governing physiological regulation and cellular and higher levels of organization are located not in the genome, but in interactive epigenetic networks which themselves organize genomic response to environmental signaling.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hood, L. 1992. In: The Code of Codes. D. J. Kevles and L. Hood. (Eds.) Harvard University Press, Cambridge, Massachusetts.
Mckeown, T. 1979. The Role of Medicine: Dream, Mirage or Nemesis? Princeton University Press, Princeton, New Jersey.
Casky, T. 1992. In: The Code of Codes. D. J. Kevles and L. Hood. (Eds.) Harvard University Press, Cambridge, Massachusetts.
Strohman, R.C. 1993. Ancient Genomes, Wise Bodies, Unhealthy People: Limits of Genetic Thinking in Biology and Medicine. Perspectives in Biology & Medicine 37(1): 112–145
Lewontin, R.C. 1992. Biology As Ideology. Harper Perennial, New York.
Wahlsten, D. 1990. Insensitivity of the analysis of variance to heredity-environment interaction. Behav. and Brain Sci. 13: 109–161.
Tautz, D. 1992. Redundancies, development and the flow of information. BioEssays 14: 263–266.
Wilkins, A.S. 1993. Genetic Analysis of Animal Development, 2nd Ed., p. 473. Wiley-Liss Press, New York.
Wright, S. 1941. The physiology of the gene. Physiological Reviews. 21: 487–527.
Kuhn, T. 1962. The Structure of Scientific Revolutions. The University ofChicago Press, Chicago, Illinois.
Brenner, S., Dove, W., Hewrskowitz, I. and Thomas, R. 1990. Genes and development: molecular and logical themes. Genetics 126: 479–486.
Weatherall, D.J. 1982. The new genetics and clinical practice. Nuffield Provincial Hospitals Trust, London.
Coggan, A.R., Spina, R.J., Rogers, M.A., King, D.S., Brown, M., Nemeth, P.M. and Holloszy, J.O. 1990. Histochemical and enzymatic characteristics of skeletal muscle in master athletes. J. Applied Physiology 68: 1896–1901.
Pette, D. and Dusterhoft, S. 1992. Altered gene expression in fast-twitch muscle induced by chronic low-frequency stimulation. Am. J. Physiol. 262: 333–338.
Kaufmann, S. 1993. The Origins of Order. Oxford University Press, Oxford.
Skinner, J.E., Molnar, M., Vybiral, T. and Mitra, M. 1992. Application of chaos theory to biology and medicine. Integ. Physiol. & Behav. Sci. 27: 39–53.
Sing, C.F. and Reilley, S.L. 1993. Genetics of common diseases that aggregate but do not segregate in families. p. 140–161. In: Genetics of Cellular, Individual, Family and Population Variability. Sing, C. F., Hanis, C. L. (Eds.). Oxford Univ. Press, Oxford.
Nathan, C. and Sporn, M. 1991. Cytokines in context. J. Cell Biol. 113: 981–986.
McKeown, T. 1988. The Origins of Human Disease. Basil Blackwell, Inc., Oxford.
Feldman, M.W. and Lewontin, R.C. 1975. The heritability hang-up. Science 190: 1163–1168.
Gillespie, J.H. and Turelli, M. 1989. Genotype-environment interactions and the maintenance of polygenic variation. Genetics 121: 129–138.
Lander, E.S. and Botstein, D. 1986. Strategies for studying heterogeneous genetic traits in humans by using a linkage map of restriction fragment length polymorphisms. Proc. Natl. Acad. Sci. USA 83: 735–737.
Jacob, H.J., Linkpaintner, K., Lincoln, S.E., Kusumi, K., Bunker, R.K., Mao, Y.P., Ganten, D., Dzau, V.J. and Lander, E.S. 1991. Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell 67: 213–224.
Cambien, F., Poirier, O., Lecref, L., Evans, A., Cambou, J.P., Arveiler, D., Luc, G., Bard, J.M., Bara, L., Ricard, S., Tiret, L., Amouyel, P., AlhencGerlas, F. and Soubrier, F. 1992. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for mycardial infarction. Nature 359: 641–644.
Myers, M.M., Branelli, S.A., Squire, J.M., Shindeldecker, R.D. and Hofer, M.A. 1989. Maternal behavior of SHR rats and its relationship to offspring blood pressures. Develop. Psychobiol. 22(1): 29–53.
Urata, H., Healy, B., Stewart, R.W., Bumpus, F.M. and Husain, A. Angiotensin. 1990. II-forming pathways in normal and failing human hearts. Circulation Res. 66: 883–890.
Peterson, L.H. 1972. Neural and Psychological Mechanisms in Cardiovascular Disease. Casa Editrice, Milano, Italy.
Kurtz, T.W. 1992. The ACE of hearts. Nature 359: 588–589.
Sherringtion, R., Brynjolfsson, J., Petursson, H., Potter, M., Dudleston, K., Barraclough, B., Wasmuth, J., Dobbs, M. and Gurling, H. 1988. Localization of a susceptibility locus for schizophrenia on chromosome 5. Nature 336: 164–167.
Kennedy, J.L., Giuffra, L.A., Moises, H.W., Cavalli-Sforza, L.L., Pakstis, A.J., Kidd, J.R., Catiglione, C.M., Sjogren, B., Wetterberg, L. and Kidd, K.K. 1988. Evidence against linkage of schizophrenia to markers on chromosome 5 in a northern Swedish pedigree. Nature 336: 167–170.
Ayala, F.J. and Kiger, J.A. Jr. 1984. Modern Genetics, 2nd ed. Benjamin/Cummings Pub. Co., Menlo Park, California.
Stent, G. 1981. Strength and weakness of the genetic approach to the development of the nervous system. Ann. Rev. Neurosci. 4: 163–194.
Phillips, D.I.W. 1993. Twin studies in medical research: can they tell us whether diseases are genetically determined? The Lancet 341: 1008–1009.
Bracha, H.S., Torrey, E.F., Bigelow, L.B., Lohr, J.B. and Linigton, B.B. 1991. Subtle signs of prenatal maldevelopment of the hand ectoderm in schizophrenia: a preliminary monozygotic twin study. Biol. Psychiatry. 30: 719–725.
Egeland, J.A., Gerhard, D.S., Pauls, D.L., Sussex, J.N., Kidd, K.K., Alien, C.R., Hosteller, A.M. and Housman, D.E. 1987. Biopolar affective disorders linked to DNA markers on chromosome 11. Nature 325: 783–787.
Kelsoe, J.R., Ginns, E.I., Egeland, J.A., Gerhard, D.S., Goldstein, A.M., Bale, S. J., Pauls, D.L., Long, R.T., Kidd, K.K., Conte, G., Housman, D.E. and Paul, S.M. 1989. Re-evaluation of Ihe linkage relationship between chromosome 11p loci and the gene for bipolar affective disorder in the Old Order Amish. Nature 342: 238–243.
Hodgkinson, S., Sherrington, R., Gurling, H., Marchbanks, R., Reeders, S., Mallet, J., Mcinnis, M., Peturrson, H., and Brynjolfsson, J. 1987. Molecular genetic evidence for heterogenity in manic depression. Nature 325: 805–806.
Baron, M. 1991. X-linkage and manic-depressive illness: a reassessment. Social Biol. 38: 179–88.
New hunt on for bipolar genes. 1993. Science 262: 651.
Gottlieb, G. 1992. Individual Developmenl and Evolution, p. xxx–xxx?. In: The Genesis of Novel Behavior. Oxford University Press, Oxford.
Levine, A.J., Momand, J. and Finlay, C.A. 1991. The p53 tumour suppressor gene. Nature 351: 453–456.
Jacks, T., Faneli, A., Schmitt, E.M., Bronson, R.T. Goodell, M.A. and Weinberg, R.A. 1992. Effects of an Rb mutation in the mouse. Nature 359: 295–300.
Donehower, L.A., Harvey, M., Slagle, B.L., Mcarthur, M.J., Montgomery, C.A. Jr., Butel, J.S. and Bradley, A. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356: 215–221.
Baker, S.J., Markowitz, S., Fearon, E.R., Willson, J.K. and Vogelstein, B. 1990. Suppression of human coloreclal carcinoma cell growth by wild-type p53. Science 249: 912–915.
Pietenpol, J.A. and Vogelstein, B. 1993. No room at the p53 inn. Nature 356: 17–18.
Dutta, A., Ruppert, J.M., Aster, J.C. and Winchester, E. 1993. Inhibition of DNA replication factor RPA by p53. Nature 365: 79–82.
Duesberg, P.H. and Schwartz, J.R. 1992. Latent viruses and mutated oncogenes: no evidence for pathogenicity. Progress in Nucleic Acid Research and Molecular Biology 43: 135–204.
Knudson, A. 1985. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res. 45: 1437–43.
Benedict, W.F., Banetjee, A., Mark, C. and Murphee, A. 1983. Nonrandom chromosomal changes in untreated retinoblastoma. Cancer Genetics and Cyotgenetics 10: 311–333.
Gardner, H.A., Gallie, B.L., Knight, L.A. and Phillips, R.A. 1982. Multiple karyotypic changes in relinoblastoma tumor cells: presence of normal chromosome No. 13 in most tumors. Cancer Genetics and Cyotgenetics 6: 201–211.
Bookstein, R., Shew, J.Y, Chen, P.L., Scully, P. and Lee, W.H. 1990. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 247: 712–715.
Xu, H.J., Sumegi, J., Hu, S.X., Banerjee, A., Uzvolgyi, E., Klein, G. and Benedict, W.F. 1991. Intraocular tumor function of RB reconstituted retinoblastoma cells. Cancer Research 51: 4481–4485.
Colditz, G.A., Willett, W.C., Hunter, D.J., Stampfer, M.J., Manson, J.E., Hennekens, C.H., Rosner, B.A. and Speizer, F.E. 1993. Family history, age, and risk of breast cancer. JAMA 270: 338–343.
Rubin, H. 1985. Cancer as a dynamic developmental disease. Cancer Res. 45: 2935–2942.
Farber, E. and Rubin, H. 1991. Cellular adaptation in the origin and development of cancer. Cancer Res. 51: 2751–2761.
Hall, J.M., Lee, M.K., Newman, B., Morrow, J.E., Anderson, L.A., Huey, B. and King, M.C. 1990. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250: 1684–1689.
Tsui, L. 1992. The spectrum of cystic fibrosis mutations. Trends in Genet. 8: 392–398.
The Cystic Fibrosis Genolype-Phenotype Consortium, 1993. Correlation between genotype and phenotype in patients with cystic fibrosis. N. Engl. J. Med. 329: 1308–1313.
Collins, F.S. 1992. Cystic Fibrosis: Molecular biology and therapeutic implications. Science 256: 774–777.
Miller, S.S., Jiang, C., Finkbeiner, W.E., Widdicombe, J.H. and McCray,Jr. P.B. Altered fluid transport across airway epithelium in cystic fibrosis. Science 262: 424–427.
Black, W.C. and Welch, H.G. 1993. Advances in diagnostic imaging and overestimation of disease prevalence and Ihe benefits of therapy. NEJM. 328: 1237–1243.
Harach, H.R., Franssila, K.O. and Wasenius, V.M. 1985. Occult papillary carcinoma of the thyroid: a “normal” finding in Finland: a systematic autopsy study. Cancer 56: 531–538.
Moertel, C.G., Fleming, T.R., Macdonald and J.S. et al. 1993. An evaluation of the carcinoembryonic antigen (CEA) lesl for monitoring patients with resected colon cancer. JAMA 270: 943–947.
Fortuin, M., Chotard, J., Jack, A.D., Maine, N.P., Mendy, M., Hall, A.J., Inskip, H.M., George, M.O. and Whittle, H.C. 1993. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation. Lancet 341: 1129–1131.
Tabor, E., Gerety, R.J. and Drucker, J.A. 1978. Transmission of non-A, non-B hepatitis from man to chimpanzee. Lancet 1: 463–465.
Reyes, G.R. and Baroudy, B.M. 1991. Molecular biology of non-A, non-B, hepatitis agents: Hepatitis C and Hepatitis E viruses. Advances in Virus Research 40: 57–102.
Choo, Q.L., Kuo, G., Weiner, A.J., Overby, L.R., Bradley, D.W. and Houghton. M. 1989. Isolation of a cDNA clone derived from a blood-born non-A, non-B viral hepatatitis genome. Science 244: 359–362.
Weiner, A.J., Kuo, G., Bradley, D.W., Bonino, F., Saracco, G., Lee, C., Rosenblatt, J., Choo, Q.L. and Houghton, M. 1990. Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet 335: 1–3.
Selby, M.J., Choo, Q., Berger, K., Kuo, G., Glazer, E., Eckart, M., Lee, C., Chien, D., Kuo, C. and Houghton, M. 1993. Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J. of Gen. Virol. 74: 1103–1113.
Seeff, L.B., Buskell-Bales, Z., Wright, E.C., Durako, S.J., Alter, H.J., Iber, F.L., Hollinger, F.B., Gitnick, G., Knodell, R.G., Perrillo, R.P., Stevens, C.E. and Hollingsworth, C.G. 1992. Long-term mortality after transfusion-associated non-A, non-B hepatitis. NEJM 327: 1906–1911.
Czaja, A.J. 1992. Chronic hepatitis C virus infection—A disease in waiting? NEJM 327: 1949–1950.
Thomas,C., Mullis, K.B., Ellison, B.J. and Johnson, P. 1993. Why there is still an HIV controversy. Nature, submitted in November 1993; rejected December 1993, manuscript available upon request (RS).
Duesberg, P.H. 1992. AIDS acquired by drug consumption and other noncontagious risk factors. Pharmac. Ther. 55: 201–277.
Aldhous, P. 1992 The promise and pitfalls of molecular genetics. Science 257: 164–165.
Plomin, R., DeFries, J.C. and McClearn, G.E. 1990. Behavioral Genetics, 2nd ed. W. H. Freeman, New York.
Garber, A.M., Littenberg, B., Sox, H.C., Wagner, J.L. and Gluck, M. 1991. Costs and health consequences of cholesterol screening for asymptomatic older Americans. Arch. Internal Med. 151: 1089–1095.
Moore, T.J. 1989. Heart Failure: A Critical Inquiry Into American Medicine and The Revolution in Heart Care. Random House, Inc., New York.
Fishel, R., Lescoe, M.K., Rao, M.R.S., Copeland, N.G., Jenkins, N.A., Garber, J. and Kolodner, R.D. 1993. The human imitator gene homologue MSH2 and its association with hereditary non-polyposis colon cancer. Cell 75: 1027–1038.
Sapp, J. 1987. Beyond the Gene: Cytoplasmic Inheritance and the Struggle for Authority in Genetics. Oxford University Press, Oxford.
Clark, M.M., Karpluk, P. and Galef, B.G. 1993. Hormonally mediated inheritance of acquired characteristics in Mongolian gerbils. Nature 364: 712.
Nanny, D.L. 1982. Genes andphenes in Tetrahymena. BioScience. 32: 783–788.
Wilson, A.C., Carlson, S.S. and White, T.J. 1977. Biochemical Evolution. Ann. Rev. Biochem. 46: 573–639.
Maddox, J. 1992. Is molecular biology yet a science? Nature 355: 201.
Maddox, J. 1992. Finding wood among the trees. Nature 356: 11.
Elsasser, W. 1987. Reflections on the Theory of Organisms, Orbis Publishing, Quebec.
McClintock, B. 1984. The significance of responses of the genome to challenge. Science 226: 792–801.
Bond, W.C., Bohs, C., Ebey, J. and Wolf, S. 1973. Rhythmic heart rate variability (sinus arrhythmia) related to stages of sleep. Conditional Reflex 8: 98–107.
Skinner, J.E., Goldberger, Mayer-Kress, G. and Ideker, R.E. 1990. Chaos in the heart: implications for clinical cardiology. Bio/Technology 8: 1018–1033.
Cripps, T.R., Malik, M., Farrell, T.G. and Camm, A.J. 1991. Prognostic value of reduced heart rate variability after myocardial infarction: clinical evaluation of a new analysis method. Br. Heart J. 65: 14–19.
Basar, E. 1993. Chaotic dynamics and resonance phenomena in brain function: progress, perspectives, & thoughts. In: Chaos in Brain Function. E. Basar (Ed.). Springer-Verlag. Berlin.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Strohman, R. Epigenesis: The Missing Beat in Biotechnology?. Nat Biotechnol 12, 156–164 (1994). https://doi.org/10.1038/nbt0294-156
Issue Date:
DOI: https://doi.org/10.1038/nbt0294-156
This article is cited by
-
Mutationen des Gendiskurses: Der genetische Determinismus nach dem Humangenomprojekt
Leviathan (2002)
-
Is there conscious choice in directed mutation, phenocopies, and related phenomena? An answer based on quantum measurement theory
Integrative Physiological and Behavioral Science (1997)